| Literature DB >> 36062035 |
Suhail Sarwar Siddiqui1, Nibu Dominic2, Sukriti Kumar3, Kauser Usman4, Sai Saran1, Avinash Agrawal1, Mohan Gurjar5, Syed Nabeel Muzaffar1.
Abstract
Sheehan's syndrome is a life-threatening endocrine emergency seen in postpartum females secondary to ischemic pituitary necrosis. It is a frequent cause of hypopituitarism in developing countries that occurs secondary to postpartum haemorrhage (PPH). Patients with Sheehan's syndrome often present with organ dysfunctions in critical care settings, secondary to stressors precipitating the underlying hormonal deficiencies. The initial clinical picture of Sheehan's syndrome may mimic some other disease, leading to misdiagnosis and diagnostic delay. Strict vigilance, timely diagnosis, and appropriate management are essential to avoid diagnostic delay and to improve the patient outcome. In this case series, we describe 5 cases of previously undiagnosed Sheehan's syndrome (including young, middle aged and postmenopausal females) that presented to critical care and emergency settings with organ failures.Entities:
Keywords: Sheehan’s syndrome; hypopituitarism; pituitary necrosis; postpartum haemorrhage
Year: 2022 PMID: 36062035 PMCID: PMC9396951 DOI: 10.2478/jccm-2022-0018
Source DB: PubMed Journal: J Crit Care Med (Targu Mures) ISSN: 2393-1817
Fig. 1(a) Sagittal (red bold arrow) and (b) Coronal T2 weighted (red bold arrow-head) images showing sella filled with CSF and thinned and flattened pituitary (height reduced) lying against floor of sella - partially empty sella. Figure 2: (a) Sagittal T2 weighted (red bold arrow) and (b) Coronal post contrast T1 weighted (red bold arrow-head) images showing reduced pituitary height (2.1mm -as measured between calipers in 2a). Figure 3: (a) Sagittal (red bold arrow) and (b) Coronal T2 weighted (red bold arrow-head) images showing sella filled with CSF and pituitary gland severely thinned, lying flattened against sellar floor.
Case descriptions.
| Case 1 | Case 2 | Case 3 | Case 4 | Case 5 | |
|---|---|---|---|---|---|
| Demographics | |||||
| Age (years) | 41 | 34 | 28 | 54 | 53 |
| Weight (Kg) | 65 | 45 | 56 | 47 | 53 |
| Height (cm) | 150 | 148 | 147 | 159 | 144 |
| Co-morbidities | Epilepsy | No | No | No | Systemic hypertension |
| PPH | Yes | Yes | Yes | Yes | Yes |
| Hysterectomy | Yes | Yes | No | No | No |
| Amenorhoea | Yes | Yes | Yes | No | Yes |
| Agalactia | Yes | Yes | Yes | Yes | No |
| Delay in diagnosis post-PPH (years) | 8 | 3 | 2 | 20 | 18 |
|
| |||||
| Clinical presentation | |||||
| Encephalopathy | Yes | Yes | Yes | Yes | Yes |
| Hypotension | Yes | Yes | Yes | Yes | No |
| Vasopressors | Yes | Yes | No | No | No |
| Bradycardia | Yes | Yes | Yes | Yes | No |
| LV dysfunction (2D ECHO) | Yes (LVEF 40%) | Yes (LVEF 30%) | No | No | No |
| MV | No | Yes | No | No | No |
| AKI | Yes | No | No | No | No |
| Polyuria | Yes | No | No | No | No |
| Hypoglycemia | Yes | No | Yes | Yes | No |
| Hematological dysfunction | Yes | No | Yes | Yes | No |
| Labs at admission | |||||
| Hb (g/dl) | 7.4 | 10.4 | 9.3 | 8.8 | 12.3 |
| TLC ( /mm3) | 3800 | 5700 | 6100 | 11000 | 4500 |
| Platelets (lacs/ mm3) | 0.75 | 5.1 | 0.75 | 5.5 | 3.5 |
| Urea/Creatinine (mg/dl) | 21/1.0 | 22/0.5 | -/0.7 | 28/0.6 | -/0.5 |
| Na (mEq/L) | 119 | 131 | 113 | 127 | 118 |
| K (mEq/L) | 4.2 | 4.04 | 3.84 | 5.0 | 3.3 |
| T Bil | 0.61 | 0.35 | - | 0.68 | 0.83 |
| D bil | 0.31 | 0.25 | - | 0.30 | 0.39 |
| SGOT/SGPT | 93/47 | 24/10 | /90 | 24/29 | 104/34 |
| ALP | 411 | 219 | - | 112 | 35 |
| Procalcitonin (micg/L) (N: 0-0.05) | 0.11 | 0.73 | - | - | - |
| Pro-BNP (pg/ml) (N: 0-125) | 294 | 7880 | - | - | - |
| USG abdomen | Post-hysterectomy with bilateral adnexal mass with complex septated cystic lesion. | Post-hysterectomy with very minimal pockets of collection. Abdominal drain in position. | Small uterus size | - | Mild left sided pleural effusion |
PPH=Postpartum haemorrhage, MV=Mechanical ventilation, LV dysfunction=Left ventricular dysfunction, LVEF=Left Ventricular Ejection fraction, AKI=Acute Kidney Injury, Polyuria=urine output > 3 Litres/ day, Hypoglycaemia=RBS < 70 mg/dl, 2D ECHO=2 dimensional echocardiography, Hb= Haemoglobin, TLC=Total Leukocyte count, Na=Serum sodium, K=serum potassium, T Bil=Total Bilirubin, D Bil=Direct bilirubin, SGOT/SGPT=Serum glutamate oxaloacetate transaminase/Serum glutamate pyruvate transaminase, ALP=alkaline phosphatase, PRO-BNP=PRO-Brain Natriuretic Peptide, N=normal, - data not available
Hormonal profile at admission.
| Hormones | Baseline values | Case 1 | Case 2 | Case 3 | Case 4 | Case 5 |
|---|---|---|---|---|---|---|
| Human GH by CLIA (ng/ml) | Females: 0-8 | - | - |
|
|
|
| LH (mIU/ml) by CMIA | Normally menstruating females: | 4.9 |
|
|
|
|
| Follicular phase: 2.39-6.60 | ||||||
| Mid-cycle peak: 3.06-74.24 | ||||||
| Luteal phase: 0.9-9.33 | ||||||
| Post-menopausal females: 10.39- | ||||||
| 64.57 | ||||||
|
| ||||||
| FSH (mIU/ml) by CMIA | Normally menstruating females: | 9.92 |
|
|
|
|
| Follicular phase: 3.03-8.08 | ||||||
| Mid-cycle peak: 2.55-16.69 | ||||||
| Luteal phase: 1.38-5.47 | ||||||
| Post-menopausal females: 26.72- | ||||||
| 133.41 | ||||||
|
| ||||||
| Estradiol (pg/ml) by CLIA | Normally menstruating females: |
|
|
|
|
|
| Follicular phase: 21-251 | ||||||
| Mid-cycle peak: 38-649 | ||||||
| Luteal phase: 21-312 | ||||||
| Post-menopausal females: | ||||||
| Not on HRT: < 10-28 | ||||||
| On HRT: < 10-144 | ||||||
|
| ||||||
| ACTH (pg/ml) by CLIA |
|
|
|
|
| |
|
| ||||||
| Morning serum cortisol (micg/dl) by CMIA | 5-23 |
|
|
|
|
|
|
| ||||||
| Thyroid profile by CLIA |
|
| ||||
| T3 (ng/ml) | 0.58-1.59 |
|
|
| ||
| Free T4 (ng/dl) | 0.8-1.8 |
|
|
|
|
|
| T4 (micg/dl) | 4.87-11.72 | |||||
| TSH (microIU/ml) | 0.35-4.94 |
|
|
|
|
|
|
| 4.08 |
|
|
| ||
|
| ||||||
| Prolactin (ng/ml) by CLIA | Females: | 0.76 | 0.88 | 1.5 | 8.8 | - |
| Non-pregnant: 2.8-29.2 | ||||||
| Pregnancy: 9.7-208.5 | ||||||
| Post-menopausal: 1.8-20.3 | ||||||
LH=Luteinizing Hormone, FSH=Follicle Stimulating Hormone, TSH=Thyroid Stimulating Hormone, ACTH=Adrenocorticotropic hormone, GH=Growth Hormone, HRT= Hormone Replacement Therapy, CLIA=Chemi Luminescent Immunoassay, CMIA=ChemiLuminescent Microparticle Immunoassay, - not done, bold hormonal values represent hormonal deficiencies
Case reports of Sheehan’s syndrome (SS) from India and other countries.
| Age/PPH/Delay | Clinical presentation | Hormonal profile | Radiology | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Year; Country; Age of patient | PPH | Delay (yrs) | Agalactia | Menstrual problem | Non-specific | Organ failures | Na | GH | PRL | Hypothyroidism | Hypogonadism | Adrenal insufficiency | Pituitary size | Sella volume (ml) | ||||
| TSH | fT3 | fT4 | LH | FSH | ACTH | Cortisol | ||||||||||||
| 2020;16
| yes | 4 | yes | yes | yes | Asthenia, anaemia | ↓ | - | ↓ | ↓ | ↓ | ↓ | ↓/N | ↓ | - | ↓ | ↓ | - |
|
| ||||||||||||||||||
| 2019;17
| yes | 7 | yes | yes | yes | Myxoedema coma, Coagulopathy, Pancytopenia, Hypoglycaemia | ↓ | - | - | N | ↓ | ↓ | ↓/N | ↓/N | - | ↓ |
| Partially empty sella |
|
| ||||||||||||||||||
| 2016; 18 India 32y/F | yes | 1 | yes | yes | yes | Anaemia, | - | - | - | ↓ | - | - | - | ↓ | - | ↓ |
| Empty sella |
|
| ||||||||||||||||||
| 2013; 19 India 41y/F | yes | 22 | yes | yes | yes | Hypoglycaemia Asthenia | ↓ | - | - | - | ↓ | ↓ | - | - | ↓ | ↓ |
| - |
|
| ||||||||||||||||||
| 2019;3 USA 36y/F | yes | 8 | yes | yes | yes | Chronic pain upper and lower limbs, Hypoglycaemia | ↓ | ↓ | N | ↓ | ↓ | ↓ | ↓ | - | ↓ | CSF in pituitary fossa | Empty sella | |
|
| ||||||||||||||||||
| 2013;21 Italy 64y/F | - | 30 | - | - | yes | Rhabdomyolysis, hypothyroidism |
| - | - | - | - | - | - | - | ↓ | Atrophy | - | |
|
| ||||||||||||||||||
| 2013;22 Nepal 38y/F | yes | 5 | - | yes | yes | Sparse hair, Dyspnoea, Bradycardia, Shock | ↓ | ↓ | ↓ | N | ↓ | ↓ | ↓ | - | ↓ |
| Empty sella | |
PPH=Postpartum haemorrhage, Delay = diagnostic delay from PPH to diagnosis of Sheehan’s syndrome, Na=Serum Sodium, GH=Growth hormone, PRL=Prolactin, TSH=Thyroid stimulating hormone, fT3=free Triiodothyronine, T4=levothyroxine, FT4=free levothyroxine LH=Leutenizing hormone, FSH=Follicle stimulating hormone, ACTH=Adrenocorticotrophic hormone, MRI=Magnetic resonance imaging (MRI) brain, N=Normal, =Postpartum haemorrhage, Delay = diagnostic delay from event to presentation, Na=Serum Sodium, GH=Growth hormone, PRL=Prolactin, TSH=Thyroid stimulating hormone, fT3=free Triiodothyronine, T4=levothyroxine, FT4=free levothyroxine LH=Leutenizing hormone, FSH=Follicle stimulating hormone, ACTH=Adrenocorticotrophic hormone, MRI=Magnetic resonance imaging brain, N=Normal, ↓= decrease, mnths=months, d=day,- = data not available